Showing results (431-440 of 484) with videos related to
Sort By:
Pageof 49
Lab on a Chip|August 24, 2013
Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochipsChristopher M Earhart, Casey E Hughes, Richard S Gaster, et al.Circulation Research|February 11, 2025
Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy MyocarditisYuhsin Vivian Huang, Yin Sun, Harrison Chou, et al.Clinical Lung Cancer|July 14, 2023
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
THE IMPACT OF ROUTINE CARDIAC TROPONIN I-BASED CARDIOTOXICITY SCREENING ON CLINICAL OUTCOMES IN PATIENTS ON CANCER IMMUNOTHERAPYMaja Ivanovic, Antonia Chan, Evaline Cheng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter StudyLeora Horn, Jeffrey R Infante, Karen L Reckamp, et al.JCO Precision Oncology|March 30, 2026
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung CancersEmily A Miao, Beow Yeap, Sameh Daher, et al.Journal of Patient-Reported Outcomes|September 15, 2021
Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancerOlga Generalova, Mohana Roy, Evan Hall, et al.Journal for Immunotherapy of Cancer|July 15, 2025
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancerNatalie J Miller, Christina Baik, Joel W Neal, et al.Annals of Internal Medicine|December 15, 2025
Eligibility and Prognostic Performance of Smoking Duration-Based Versus Pack-Year-Based U.S. National Lung Cancer Screening Criteria Across Racial and Ethnic GroupsChloe C Su, Victoria Y Ding, Kevin Ten Haaf, et al.Arthritis and Rheumatism|July 13, 2002
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritisTino Munster, John P Gibbs, Danny Shen, et al.Pageof 49